TSX : HLS.TO

HLS Therapeutics Inc. — SEC Filings

$4.2 CAD

-$0.01 (-0.24%)

Volume
1.36K
Average Volume
35.17K
Market Capitalization
$131.35M
P/E Ratio
-9.34
Dividend Yield
0.00%
Price Target
Year High
$5.77
Year Low
$0.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.00
HLS.TO SEC Filings
Company Symbol Filed Form Type View